Concepedia

Lubomir Antalik

LA

3

Publications

194

Citations

3

H-Index

2018

Active since

Affiliations

The George Institute for Global Health(Current)

Rigshospitalet

Harvard University

Universidad Nacional de Córdoba

AstraZeneca (Sweden)

Lubomir Antalik is an author at The George Institute for Global Health.

Publications per year

2018–2021

3

Publications

3

A Randomized, Double‐Blind, Placebo‐Controlled Study to Evaluate the Effect of Erenumab on Exercise Time During a Treadmill Test in Patients With Stable Angina

Christophe Depré, Lubomir Antalik, Amaal J. Starling et al. · Headache The Journal of Head and Face Pain · 2018 · 135 citations · Full text

Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy

Kieran F. Docherty, Pardeep S. Jhund, Olof Bengtsson et al. · Diabetes Care · 2020 · 42 citations · Full text

Extrapolating Long-term Event-Free and Overall Survival With Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction

Kieran F. Docherty, Pardeep S. Jhund, Brian Claggett et al. · JAMA Cardiology · 2021 · 17 citations · Full text

Rows per page

1–3 of 3